Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats
ConclusionsLiraglutide may exert a renoprotective effect via prevention of glomerular endothelial abnormality and preservation of autophagy in early-phase DKD, independent of blood glucose, and blood pressure levels.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Glomeruli | Hydralazine | Hypertension | Insulin | Obesity | Study | Urology & Nephrology | Victoza